Insights

Justin brings more than two decades of experience as a healthcare operator, with a track record of scaling multisite services businesses and delivering strong outcomes for investors Paul Evans continues as Chair of the Board to support Velocity’s growth strategy as it enters its next phase The appointment reinforces Velocity’s mission to improve the clinical … Read more

Full network expansion to all studies at 70+ global locations follows a year-long collaboration that improved show-rates by up to 9 percentage points across nearly 100k scheduled screenings.  Today, we are excited to announce that Velocity Clinical Research, the world’s largest organization of fully owned and integrated clinical research sites, is deepening its aligned partnership … Read more

By Nick Spittal, Chief Operations Officer, Velocity Clinical Research  Most sponsors and CROs talk about slow sites, hard-to-find patients, and protocol complexity putting their studies at risk. Those issues are all real, and they frequently share the same underlying cause: the disparate operating model used across individual study sites. In my experience, study risk often … Read more

At Velocity Clinical Research Albuquerque, clinical research is being delivered in a way that reflects the community it serves. Led by Dr. Sara Friedman, a Principal Investigator with a background in OB/GYN, the Albuquerque site is a female-led team focused on women’s health and vaccines. Their work sits at the intersection of scientific rigor and … Read more

Douglas Logan, MD, recently retired from Velocity, but his presence is as big as ever. Talk to our U.S. PIs about their route into research, or their experience at Velocity, and his name is likely to come up. For Matthew Wenker, MD, that story goes back nearly two decades. When he first stepped into clinical … Read more

For much of her early career, Abbie Youkilis, MD focused on changing healthcare from the outside in. Having begun as a pre-med student at Duke, she pivoted into public policy, earning a master’s degree from Harvard and working in Washington on health policy and aging issues. But over time, she found herself drawn back to … Read more

There is a logic to the way William Cromwell, MD speaks about cardiometabolic risk — if this, then that. But you never feel as though it would come at the expense of the person sitting opposite him. Over the past 35 years of specialty practice, research, teaching, and publishing, his emphasis has remained the same. … Read more